Validation of a Multi-gene Test for Lung Cancer Risk

Running, not enrolling

Conditions studied: Lung Cancer

In brief

The purpose of this study is to determine the validity of a multi-gene Lung Cancer Risk Test (LCRT). In the process, the investigators will establish a bank of NBEC samples and corresponding blood samples from individuals demographically at increased risk for lung cancer.

Key facts

Study ID

NCT01130285

Run by

University of Toledo Health Science Campus

People needed

403

Starts

2011-05-01

Expected to finish

2026-09-01

Last updated by the study team

2025-06-10

Who can join

Age: 50 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 20 or more pack year smoking history
• clinical need for diagnostic bronchoscopy or consent to study driven bronchoscopy

You may not qualify if…

• Lung Cancer within 3 months after the date of enrollment

Where it is running

• National Jewish Health — Denver, Colorado, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Henry Ford — Detroit, Michigan, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Cleveland Clinic Foundation — Cleveland, Ohio, United States
• Ohio State University — Columbus, Ohio, United States
• The Toledo Hospital — Toledo, Ohio, United States
• Mercy St. Vincent Medical Center — Toledo, Ohio, United States
• University of Toledo, Health Science Campus — Toledo, Ohio, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• Tennessee Valley Veterans Admin. — Nashville, Tennessee, United States
• Vanderbilt — Nashville, Tennessee, United States
• Inova Fairfax Hospital — Falls Church, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.